CXS chemgenex pharmaceuticals ltd
Add to My Watchlist 0.00% ! 70.0¢

oncologic drugs advisory committee meeting

  1. adder
    520 Posts.
    clock Created with Sketch.
    24/02/10
    12:15
    Post #: 6370158
    Oncologic Drugs Advisory Committee Meeting

    February 10, 2010

    NDA 22-374

    Omacetaxine (Omapro)

    ChemGenex Pharmaceuticals

    http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM199561.pdf
    CXS Price at posting: 71.5¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Arrowsmith North Silica Sand Project granted works approval
right-arrow Created with Sketch.
MEM Memphasys secures transformational A$325K initial order with exclusive Middle East partnership
right-arrow Created with Sketch.
NEWS Rubix advances proposed acquisition of prospective Bauxite Projects in Africa
right-arrow Created with Sketch.
NEWS Vulcan signs first major Phase One contract with NESI
right-arrow Created with Sketch.
BML Boab Metals secures path to full ownership of Sorby Hills Project
right-arrow Created with Sketch.
NEWS HotCopper Highlights: 4DS Memory's strategic review flags strategic review & more
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.